Indeed, T cells carrying a chimeric antigen receptor derived from a monoclonal antibody against HERV-K envelope glycoprotein showed significant anti-tumour activity in human melanoma xenograft mouse model [102]. This evidence concerns the gene ERVW-1 and neoplasm.